Cloud DX Grants Stock Options
Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a North American leader in Virtual Care, has granted 565,363 stock options to consultants and employees as part of a compensation and retention program.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a North American leader in Virtual Care, has granted 565,363 stock options to consultants and employees as part of a compensation and retention program. The options, with an exercise price of $0.35, will expire on February 15, 2027. Of these, 44,632 options were for company officers. A total of 4,538,490 stock options are now outstanding, with 431,730 Common Shares available for future issuance. Cloud DX aims to improve healthcare delivery through its Connected Health™ platform, recognized with multiple awards.
Positive
- Stock option grants may enhance employee retention and motivation.
- Cloud DX's Connected Health™ platform has received multiple prestigious awards, increasing credibility.
Negative
- None.
Details
News Market Reaction – CDXFF
The recorded move for CDXFF in the trading session of this news was +5.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
KITCHENER, ON / ACCESSWIRE / February 16, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), Cloud DX, ("the Company" or "Cloud DX) a leading North American Virtual Care platform provider, announces that an aggregate of 565,363 stock options were granted to consultants to, and employees of the Company as part of an overall compensation and staff retention program. 44,632 of these stock options were granted to officers of the Company. Each stock option entitles the holder thereof to purchase one common share in the capital of the Company (a "Common Share") at an exercise price of
About Cloud DX
Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." In 2021, Cloud DX became an exclusive partner of Medtronic Canada.
Cloud DX Investor Site https://ir.clouddx.com/overview/default.aspx
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Social Links
Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/
For media inquiries please contact:
Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com
For investor inquiries please contact:
Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com
SOURCE: Cloud DX Inc.
View source version on accesswire.com:
https://www.accesswire.com/689226/Cloud-DX-Grants-Stock-Options
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.